This inventor holds 20 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Kyowa Hakko Kirin Co., Limited, Kyushu University, Juki Corporation. Active years: 2000-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Machida, JP (2016)
- Tokyo, JP (2000 - 2020)
Company Filing History:
16 out of 272 
3 out of 455 
2 out of 280 
Years Active: 2000-2026
Areas of Expertise:
Title: **The Innovative Endeavors of Tsuguo Kubota**
Introduction
Tsuguo Kubota, a prominent inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology. With an impressive portfolio of 19 patents, Kubota has focused on developing antibodies that play crucial roles in therapeutic and diagnostic applications.
Latest Patents
Among his latest inventions are two noteworthy patents: the **Anti-TIM-3 antibody** and the **Anti-FOLR1 antibody**. The Anti-TIM-3 antibody is designed to target the extracellular region of TIM-3, showcasing high antibody-dependent cellular cytotoxicity (ADCC) activity. This invention encompasses not only the antibody itself and its encoding DNA but also the vectors and methods required for production, underlining its potential for therapeutic and diagnostic use. The Anti-FOLR1 antibody targets diseases associated with FOLR1-expressing cells, and like TIM-3, it exhibits significant effector activities including ADCC and complement-dependent cytotoxicity (CDC). This patent also elaborates on the processes necessary for producing these antibodies alongside their therapeutic applications.
Career Highlights
Tsuguo Kubota's career includes valuable experiences at notable organizations like Kyowa Hakko Kirin Co., Limited and Kyushu University National University Corporation. His work has led to breakthroughs in antibody development, reinforcing the importance of his contributions to medical science and innovation.
Collaborations
Throughout his career, Kubota has collaborated with distinguished colleagues including Hiroshi Ando and Shin-ichiro Takayanagi. These partnerships have fostered an environment of creativity and innovation, resulting in advancements that significantly impact the field of biotechnology.
Conclusion
Tsuguo Kubota's inventive spirit and dedication have made a lasting imprint on the biotechnology landscape. His latest patents reflect a commitment to addressing important health issues through groundbreaking scientific advancements. As an inventor, Kubota continues to inspire future innovations in the world of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile